Philips Expands Its Monitoring & Analytics Business with the Acquisition of UF Startup Xhale Assurance Inc. (Philips.com)
Royal Philips, a global leader in health technology, announced that it has acquired UF startup Xhale Assurance Inc, a US-based scale-up company developing and commercializing next-generation sensor technologies. Xhale Assurance’s unique, disposable pulse oximetry sensor is placed on the wing (ala) of the nose, and can reliably measure and transmit a patient’s heart rate and […]
USDA Awards Grant to Biotech Startup Pheronym (WCJB)
The federal government is supporting the groundbreaking work of another biotech startup in Alachua County. The USDA has awarded a $500,000 grant to Pheronym, which works out of UF Innovate | Sid Martin Biotech. Pheronym started in the Hatchery at UF Innovate | The Hub before moving to its sister business incubator. Pheronym is developing […]
Ology Bioservices Wins $8.4 Million Defense Department Award to Produce Anti-Ebola Medical Countermeasure (BioFlorida)
UF startup and UF Innovate | Sid Martin Biotech alumn Ology Bioservices, Inc., a biologics contract development and manufacturing organization (CDMO), announced that it was awarded an Other Transaction Agreement (OTA) to support the Joint Project Manager Medical Countermeasure Systems (JPM-MCS), a component of the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear […]
AxoGen Invests $5M in Dayton, Ohio, Site for Expanded Operations (Dayton Daily News)
UF startup and UF Innovate | Sid Martin Biotech alum AxoGen, a medical devices manufacturer, has purchased a Vandalia building and land for $5 million for nerve graft work. AxoGen Inc., its principal executive office located in Alachua, bought the 2,400-square-foot building at 913 Industrial Park for $5 million, Montgomery County property records show. Just […]
Oragenics, Inc. Resumes Phase 2 Clinical Trial of AG013 in Oral Mucositis Following Positive Routine Safety Review (Business Wire)
UF Innovate | Sid Martin alumni startup Oragenics, Inc., a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis (OM), announced it has resumed its Phase 2 clinical trial of AG013, a live biotherapeutic product for the potential treatment of OM following a positive review by an independent […]
Sarepta Carries Lacerta Through $30M Round (Global University Venturing)
UF Innovate | Sid Martin Biotech resident client Lacerta Therapeutics, a US-based gene therapy startup of University of Florida, received $30m in funding from biopharmaceutical firm Sarepta Therapeutics. Founded in 2017, Lacerta Therapeutics is developing gene therapy programs for rare, inherited metabolic conditions, known as lysosomal storage disorders, such as Pompe disease and the fatal […]
UF Innovate | Sid Martin Biotech Resident Company Lacerta Therapeutics, Inc. Closes On $30 million Investment Round (Business Wire)
UF Innovate | Sid Martin Biotech, the leading biotechnology incubator at the University of Florida, announces resident company Lacerta Therapeutics, Inc., has closed on a $30 million investment round. UF startup Lacerta is a clinical-stage gene therapy company using a constellation of proprietary adeno-associated virus (AAV) vector technologies to develop treatments for central nervous system […]
Gene Therapy Startup Lacerta Therapeutics Raises $30M in Equity Financing from Sarepta (MedCityNews)
A startup based out of the University of Florida developing viral vector-based gene therapies has drawn an equity investment from a larger, commercial-stage drugmaker. Lacerta Therapeutics closed on the $30 million investment round, made by Cambridge, Massachusetts-based Sarepta Therapeutics, which gives Sarepta rights to multiple Lacerta central nervous system gene therapy programs. The announcement came […]
Sarepta Dives Deeper into Gene Therapy (PharmaPhorum)
Sarepta Therapeutics has handed $30 million to UF startup and Sid Martin Biotech resident client Lacerta in exchange for a group of gene therapies, including a Pompe disease candidate. According to the agreement Sarepta will make an equity investment of $30 million in Lacerta Therapeutics gaining rights to two unnamed CNS-targeted gene therapy programs including […]
Blood Test May Eliminate Need for CT Scans after TBI (Healio)
The University of Rochester School of Medicine and Dentistry studied the accuracy of a TBI diagnostic blood test created by UF startup and Sid Martin Biotech graduate Banyan Biomarkers. A novel blood test predicted the absence of intracranial injuries on head CT scan after suspected traumatic brain injury with high accuracy, according to findings published […]